What Does Potency Actually Mean for Inhaled Corticosteroids?

  title={What Does Potency Actually Mean for Inhaled Corticosteroids?},
  author={Dennis Williams},
  journal={Journal of Asthma},
  pages={409 - 417}
Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents currently available for the treatment of persistent asthma, irrespective of severity [1-5]. Although the potential for... 
1 Citations


Comparative studies of inhaled corticosteroids in asthma.
The lack of statistical significant differences between the two preparations is proposed to indicate that the efficacy of inhaled corticosteroids delivered through different inhaler devices via standard CFC-containing preparations in current use is likely to be similar.
Measuring efficacy and safety of different inhaled corticosteroid preparations.
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society.
The objective of the Asthma Committee was to suggest a model that could be tested through a National Study and, if data were insufficient to do this, determine what other studies should be conducted.
Comparison of Inhaled Corticosteroids
  • H. Kelly
  • Medicine
    The Annals of pharmacotherapy
  • 1998
The preponderance of current data suggests that the existing inhaled corticosteroids have similar risks of producing systemic effects when administered in equipotent antiinflammatory doses as a metered-dose inhaler plus spacer or as their respective dry-powder inhaler.
Comparing inhaled corticosteroids.
  • G. Colice
  • Medicine, Biology
    Respiratory care
  • 2000
The respiratory care practitioner should be aware that estimating the clinical benefits from the topical anti-inflammatory effects of these newer products will be difficult to determine from information made available about the relative advantages and disadvantages of these new products.
Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler1
Mometasone furoate (MF) administered by dry powder inhaler (DPI) was composed with budesonide (BUD) Turbuhaler1 in the treatment of moderate
Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Metaanalysis shows that fluticasone propionate exhibits greater dose-related systemic bioactivity compared with other available inhaled corticosteroids, particularly at doses above 0.8 mg/d, and shows that the long-term systemic burden will be minimized by always trying to achieve the lowest possible maintenance dose that is associated with optimal asthmatic control and quality of life.